CAI
CAI
NASDAQ · Biotechnology

Caris Life Sciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$31.47
+0.82 (+2.68%)
As of Sep 22, 9:50 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 12 75%
Hold 4 25%
Sell 0 0%
Price Target
Analyst Price Target -1.7% upside
Low Target $20.23
Average Target $30.92
High Target $48.05
Current Price $31.47
Current
$31.47
Target
$30.92
$20.23 $30.92 avg $48.05
Scenario Analysis
Bear Case
$20.23
-35.7%
Low target
Base Case
$30.92
-1.7%
Avg target
Bull Case
$48.05
+52.7%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$34.54
-8.9% from high
52-Week Low
$14.19
+121.8% from low
50-Day SMA
$25.57
+23.1% vs SMA
RSI (14)
21.6
Oversold
Target vs 52W High
$30.92
-10.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%